Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

Press releases published on November 4, 2026

Nov. 4, 2026

Ocugen Provides Business Update with Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 4, 2026

Tonix Pharmaceuticals to Present at Guggenheim’s 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 4, 2026

Seres Therapeutics Reports Third Quarter 2026 Financial Results and Announces Plans for Advancing Development of SER-155 To Prevent Immune Checkpoint Inhibitor-Related Enterocolitis (irEC)

Indeterminate GlobeNewswire

Nov. 4, 2026

Rapport Therapeutics Reports Third Quarter 2026 Financials and Provides Business Update

Indeterminate GlobeNewswire

Nov. 4, 2026

BlossomHill Therapeutics Announces Upcoming Presentation for BH-30236, an Oral Macrocyclic CLK Inhibitor, at the 68th American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire

Nov. 4, 2026

Medicenna Completes Phase 1/2 ABILITY-1 Enrollment and Announces Webinar to Discuss Updated MDNA11 Results with Key Opinion Leaders

Indeterminate GlobeNewswire

Nov. 4, 2026

Bioxytran Secures Attested Free Sale Certification for A-SUQAR®, Opening the Path to the UAE and Gulf Markets

Indeterminate GlobeNewswire

Nov. 4, 2026

Repligen Corporation to Present at Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

Nov. 4, 2026

Biodesix to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 4, 2026

Nxera Pharma Revises Consolidated Financial Forecast for the Year Ending 31 December 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Nxera Pharma Enters into Global License Agreement with AbbVie for NXE0033744, a Novel EP4 Receptor Agonist for Inflammatory Bowel Disease

Indeterminate GlobeNewswire

Nov. 4, 2026

Boehringer Ingelheim and SBP Group enter partnership to advance next-generation cancer therapies

Indeterminate GlobeNewswire

Nov. 4, 2026

Breakthrough Therapy Designation granted by the FDA for daridorexant in pediatric insomnia disorder

Indeterminate GlobeNewswire

Nov. 4, 2026

Eliminating Static Without Electricity - MEC Industries Introduces the Powerless ECO Ionizer

Indeterminate GlobeNewswire

Nov. 4, 2026

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire